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Summary
PURPOSE: Vitamin D is primarily known for its role in
bone health. However, it has a much more diverse role
in the human metabolism. Specifically, deficiency of vita-
min D has recently been studied for its possible role in ad-
verse pregnancy outcomes such as preeclampsia, gesta-
tional diabetes and preterm birth. Vitamin D levels largely
depend on exposure to the sun and are influenced by nu-
tritional habits at only a minimal level. In Switzerland, it is
estimated that 40–50% of the population is vitamin D de-
ficient. No specific data on pregnant women is available.
The recommendations of the Swiss Federal Commission
for Nutrition include a supplement of 600 IU of vitamin D
to all pregnant women, despite the lack of data for this
population in Switzerland. The primary aim of this study
was to determine the prevalence of vitamin D deficiency
among the population of pregnant women receiving prena-
tal care and giving birth at our clinic. We assumed that the
prevalence of vitamin D deficiency in pregnant women in
Switzerland is significantly higher than what has been es-
timated. Therefore, the current recommendations for vita-
min D supplementation in pregnant women may be insuffi-
cient to achieve appropriate vitamin D levels. Furthermore,
we aimed to address the issue of the potential influence of
vitamin D deficiency on adverse pregnancy outcomes.
METHODS: We performed a retrospective, observational
cross-sectional study of 1382 pregnant women attending
prenatal care at our department between 2012 and 2015.
Serum 25-dihydroxycholecalciferol (25(OH)D) levels were
determined in the first trimester, and the patient’s charac-
teristics, the course of the pregnancy, any complications,
the delivery and the neonatal outcome were analysed. The
risk factors for vitamin D deficiency and its correlation with
adverse pregnancy outcomes were assessed using a mul-
tivariate analysis.
RESULTS: The clear majority (73.23%) of the population
studied were found to be vitamin D deficient, with serum
levels of 25(OH)D <50 nmol/l. More importantly, severe vi-
tamin D deficiency (25(OH)D levels below 25 nmol/l) was
present in one third (34.2%) of all pregnant women. The
mean 25(OH)D level was 36.72 ± 19.63 nmol/l. In the
multivariate analysis, those with a high BMI and who be-
longed to ethnicities comprising people who are general-
ly dark-skinned were found to be associated with lower
25(OH)D serum levels (p <0.0001). We detected a sea-
sonal influence: the mean 25(OH)D level was significantly
higher during the summer season (April–September) com-
pared to the winter season (October–March) (p <0.0001).
We found an association between low 25(OH)D serum
level and gestational diabetes (p = 0.0116). Surprisingly,
a low 25(OH)D level was also associated with decreased
incidence of postpartum hemorrhage and placental reten-
tion (p = 0.02). We found no association between the
25(OH)D serum level and preeclampsia, preterm birth,
postdate pregnancy, miscarriage, intrauterine growth re-
striction, bacterial vaginosis, mode of delivery, or neonatal
birth weight and length.
CONCLUSION: We performed a retrospective analysis of
serum 25(OH)D concentrations in pregnant Swiss women
and found a mean serum 25(OH)D level of about 37 nmol/
l and that one third of the overall study population had a
serum 25(OH)D level below 25 nmol/l, and were thus se-
riously vitamin D deficient. Furthermore, the data demon-
strate that vitamin D deficiency is associated with gesta-
tional diabetes. The current recommendations of vitamin D
supplementation of 600 IU in pregnant women are there-
fore insufficient, and novel strategies, such as general
screening for vitamin D deficiency, pre-conceptional timing
of the supplementation and individually tailored dosing of
vitamin D supplementation seem mandatory, potentially
leading to improved maternal health and benefits to chil-
dren’s long-term health in Switzerland and worldwide. (trial
registration ClinicalTrial.gov. Identifier: NCT02904720)
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Introduction
Vitamin D is best known as a vitamin of the calcium
and bone metabolism. More recently, vitamin D has been
shown to have many other roles in human physiology. In-
deed, vitamin D receptors are found in most of an or-
ganism’s cells, including white blood cells, and may play
a role in cell proliferation and differentiation and affect
the immune system or insulin secretion and sensitivity
[1]. Furthermore, recent reports indicate an association be-
tween low vitamin D levels and an increased risk of devel-
oping pregnancy complications such as disorders of pla-
cental implantation, pre-eclampsia, fetal growth
retardation, gestational hypertension, impaired glucose tol-
erance and gestational diabetes, preterm birth, caesarean
section, and other adverse conditions [2–5]. Recent studies
report a higher incidence of postpartum depression in cases
of vitamin D deficiency [6]. As a long-term consequence
of vitamin D deficiency, women are at risk of developing
severe osteoporosis [1]. A low vitamin D level in the moth-
er can result in maternal hypocalcaemia, which in turn is a
factor that promotes the development of neonatal seizures.
Negative effects of maternal vitamin D deficiency have al-
so been reported in the newborn and for the offspring’s
development: long-term consequences for the child may
range from rickets, increased susceptibility to respiratory
illness, autoimmune diseases like Crohn’s disease or di-
abetes mellitus type I, or even cancer, since vitamin D
also has a modulatory action on the immune system [7–9].
Lower neonatal vitamin D status is related to autism spec-
trum disorder, and a link to developmental delay has re-
cently been shown in the CHARGE case-control study
[10].
There is emerging evidence that genetic and epigenetic
factors may influence vitamin D status, and that the gene
expression profiles of healthy pregnant women change
during the course of pregnancy, suggesting that maternal
vitamin D levels influence transcriptional profiles. These
alterations of the maternal transcriptome may contribute
to fetal immune imprinting and reduce allergic sensitisa-
tion in early life [11, 12]. New data suggest that there are
indeed direct genomic alterations induced by the vitamin
D administered during pregnancy that can alter birth out-
comes [13–15].
Vitamin D is the only vitamin that can be synthesised by
the body itself, with the help of ultraviolet B (UVB) irra-
diation. Nevertheless, vitamin D deficiency is quite com-
mon. In Switzerland, the prevalence of vitamin D deficien-
cy has been shown to be 60% for the general population,
with seasonal variability [16]. There is no published data
on the prevalence of vitamin D deficiency in pregnant
women in Switzerland.
There is no consensus among health experts on the optimal
serum level of vitamin D to guarantee sufficient long-
term bone mineralisation and to support the proper func-
tioning of the whole organism. In the literature, most ex-
perts (IOM, WHO, NIH, EFSA) regard serum levels of
25(OH)D between 50 and 75 nmol/l as sufficient [17–21].
Treatment of vitamin D deficiency consists of consequent
supplementation. There are several different supplementa-
tion protocols among different countries and health insti-
tutions [22]. Unfortunately, there is currently a lack of ev-
idence concerning the best way to supplement vitamin D
and the efficacy of vitamin D supplementation to improve
pregnancy and neonatal outcomes. The current literature
has clearly demonstrated that vitamin D supplementation
is safe at up to 4000 IU/d, and to date, there are no reports
of adverse events [4, 5, 21, 23–25].
The primary aim of this study was to determine the preva-
lence of vitamin D deficiency among the population of
pregnant women receiving prenatal care and giving birth
in our clinic. Furthermore, we aimed to assess baseline vi-
tamin D levels, as well as the prevalence and degree of
severity of vitamin D deficiency among the pregnant pop-
ulation receiving care at our clinic in Switzerland. We also
aimed to compare our data to the existing data for the gen-
eral population and to compare our results to the current
Swiss guidelines, which recommend a routine supplemen-
tation of 600 IU of vitamin D to every pregnant women,
without a prior assessment of their vitamin D levels. Prior
assessment of vitamin D levels is only recommended if
risk factors are present [16]. We further wanted to identify
in our sub-population groups and confirm the known risk
factors for vitamin D deficiency among pregnant women.
We also wanted to study the influence of vitamin D on
various pregnancy outcomes and to suggest how an op-
timised management strategy for vitamin D supplementa-
tion in pregnancy might look if our results are confirmed
in further studies.
Materials and methods
Study stetting and design
In 2012, following the release of the Swiss guidelines on
vitamin D deficiency by the Federal Commission for Nu-
trition, we started collecting the baseline vitamin D lev-
els of pregnant subjects to rectify the lack of data on base-
line vitamin D levels in pregnant women and the unknown
prevalence of vitamin D deficiency in pregnant women in
Switzerland.
We now intend to provide, for the first time, data on base-
line vitamin D levels in pregnant women in Switzerland,
and to explore possible associations of these levels with
adverse pregnancy outcomes. This retrospective, obser-
vational cross-sectional study was performed at the De-
partment of Obstetrics and Gynaecology of the University
Hospital Bern in Switzerland.
The study was approved by the ethics committee of the
University of Bern (Ref.-Nr. KEK-BE: 330/2015; Basec:
2015-00063) and was registered on ClinicalTrial.gov.
(Identifier: NCT02904720).
Following the Swiss Federal Act on research involving hu-
man beings (Human Research Act, HRA) of 30 September
2011 (Status as of 1 January 2014), Art. 33–35, written in-
formed consent for further use of non-genetic health-relat-
ed personal data is not necessary.
Patient recruitment and selection
All pregnant women who had their serum vitamin D levels
measured during the first or second trimester of their preg-
nancy and who took prenatal care and had their deliveries
at our institution between 2012 and 2015 were included.
Vitamin D levels were routinely checked at the first ante-
natal visit by women taking prenatal care at our clinic. All
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data were retrieved retrospectively from the patients` elec-
tronic files.
Vitamin D supplementation and current Swiss guide-
line recommendation
In our antenatal clinic, we recommend maternal multivit-
amin supplementation with Elevit® Pronatal, Bayer, con-
taining 500 IU of vitamin D, to every patient. Additional
vitamin D is added according to their individual vitamin
D needs. The pregnant subjects were reviewed every 5–6
weeks and their history of adherence was taken. Compli-
ance was reported to be usually quite good. The costs of vi-
tamin D testing and supplementation were covered by the
Swiss health insurance system.
In our clinic, supplementation of at least 1000 IU/d was
administered orally throughout the pregnancy in cases of
deficiency. Women with adequate vitamin D levels were
routinely supplemented with 600 IU/d orally, following the
Swiss Federal Commission for Nutrition’s recommenda-
tions [16]. A follow-up measurement of the vitamin D lev-
el was not routinely performed, as it was assumed that vit-
amin D levels were adequately restored after the course of
the treatment.
Analytical method
Using blood samples obtained from a standard venipunc-
ture at admission, a quantitative laboratory analysis of
25-hydroxycholecalciferol (25(OH)D), the precursor form
of bioactive vitamin D, was performed in our Center of
Laboratory Medicine, Inselspital, University Hospital Bern
using chemiluminescent immunoassays (CLIA) on a Liai-
son XL (Diasorin).
For 25(OH)D, total internal quality control was performed
using the LIAISON by Diasorin 25 OH vitamin D total
control set (REF 310601), level 1 and 2 in each series, as
well as after calibration. The external quality control was
done by round robin tests four times a year by the Swiss
Centre for Quality Control.
For our study, we established that a sufficient 25(OH)D
level was indicated by a value >50 nmol/l. A mild deficien-
cy was present when values were between 25–49 nmol/l,
and a severe deficiency was present if levels were below
25 nmol/l [17–20].
Data acquisition
We retrospectively reviewed the electronic files of the
1382 selected patients. Relevant data such as body mass in-
dex (BMI), origin, season of testing, smoking status, preg-
nancy outcomes including the occurrence of complications
(see below), mode of birth and gestational age at birth, and
the neonatal outcomes of birth weight and length were ex-
tracted and anonymised.
Variables
The adverse pregnancy variables added to the multivariate
analysis were selected after reviewing the relevant liter-
ature, especially existing reviews and meta-analyses [24,
26–32]. The most frequently studied maternal and fetal ad-
verse outcomes were selected.
Preeclampsia was defined as systolic blood pressure ≥140
mm Hg and/or diastolic blood pressure ≥90 mm Hg at two
separate times (at least 4 hours apart) in a previously nor-
motensive patient, whether or not associated with the pres-
ence of a proteinuria ≥300 mg/24h.
Gestational diabetes mellitus (GDM) was defined follow-
ing the WHO 2013 criteria (fasting plasma glucose ≥5.1
mmol/l, 1h plasma glucose ≥10 mmol/l, or 2h plasma glu-
cose ≥ 8.5 mmol/l after a standard 75g oral glucose toler-
ance test performed around the 28th week of gestation).
Postpartum haemorrhage (PPH) was diagnosed in all vagi-
nal deliveries with a blood loss ≥500 ml.
Placental retention was diagnosed when the placenta had
not undergone expulsion within 30 minutes after the deliv-
ery.
Preterm birth was defined as a delivery which took place
before completing the 37th week of gestation.
Postdate pregnancy was defined as a delivery which took
place after the 40th week of gestation.
Miscarriage was defined as a clinically recognised preg-
nancy loss before the 20th week of gestation or as the ex-
traction of an embryo or fetus weighing ≤500 g, following
the WHO criteria.
Intrauterine growth restriction (IUGR) was diagnosed
when a fetus failed to achieve its growth potential, in the
case of progressive deviation from its growth curve or in
the case of SGA (fetus with weight <10th percentile) com-
bined with signs of placental insufficiency such as oligo-
hydramnios or abnormal umbilical artery Doppler.
Bacterial vaginosis was diagnosed in the case of clinical
symptoms of colpitis associated with a positive vaginal
smear test or following the Amsel criteria.
The mode of delivery was classified as vaginal birth or cae-
sarean section.
Statistical analysis
The primary endpoint, the prevalence of vitamin D defi-
ciency, was analysed with an empirical estimation of the
proportion of interest and with a score-type confidence in-
terval.
To identify the risk factors (BMI, ethnicity, religion, smok-
ing status, season at testing) for the numerical primary out-
come, a linear regression model was performed. The linear
regression analysis was performed by modelling the nu-
merical outcome of vitamin D status. As this was log-nor-
mally rather than normally distributed, a log transforma-
tion was applied to the outcome.
A backward selection modelling method was chosen be-
cause there were many potential risk factors for vitamin
D deficiency. Two-way interactions were also considered
in order not to miss any important effects. No adjustments
were made for potential factors due to the retrospective na-
ture of this study.
A correlation analysis was performed because associations
between several perinatal outcomes and the primary out-
come were of interest. These outcomes could not be in-
cluded in the regression model since they could not be seen
as predictors of vitamin D status.
For the analysis associations between the numerical pri-
mary endpoint and several outcomes, measurements of as-
sociations were computed. Numerical outcomes (weight,
length and gestational age at birth) were analysed with
Pearson’s correlation coefficient.
Original article Swiss Med Wkly. 2020;150:w20238
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 3 of 11
For the analysis of categorical outcomes (preeclampsia,
gestational diabetes, abortion, postpartum haemorrhage,
etc.), the numerical primary endpoint was split into two
categories describing whether a value was regarded as de-
ficient or not. Following this, odds ratios (ORs) in the case
of a dichotomous variable and chi-square tests in the case
of a nominally scaled variable were performed.
For all association measures, a confidence interval (CI) and
a p-value for the null of no association were also comput-
ed. No correction for multiple testing was applied due to
the explorative nature of this retrospective observational
study. The level of significance was set to 0.05.
All calculations for the statistical analysis were done with
R, version 3.2.2. (The R Project for Statistical Computing,
Vienna, Austria).
Results
Out of the 1382 women who had vitamin D testing at our
clinic, 229 were lost to follow-up. For the assessment of
the prevalence of vitamin D deficiency among pregnant
Swiss women, all 1382 women who had their vitamin D
levels tested were included.
For the second part of this study, which analysed the asso-
ciations between vitamin D levels and adverse pregnancy
outcomes, only the 1153 women for whom we conducted a
complete follow-up until the delivery at our clinic were in-
cluded. The baseline characteristics of the population stud-
ied are presented in figure 1 and table 1.
Prevalence of vitamin D deficiency
Among the 1382 women who had their 25(OH)D serum
level tested, only 26.77% had a sufficient vitamin D level
(≥50 nmol/l). Mild deficiency, defined as 25(OH)D levels
between 25 and 50 nmol/l, was present in 38.93%, while
severe deficiency, defined as 25(OH)D levels below 25
nmol/l, was present in 34.2% of all the women tested,
which gives an overall rate of vitamin D deficiency
(25(OH)D < 50 nmol/l) of 73.23%. These results are pre-
sented in table 2.
The mean 25(OH)D serum level was 36.72 nmol/l (SD
19.6).
Table 1: Baseline characteristics of the population studied.
Patients with 25(OH)D testing 1382
Testing period from April to September (%) 677 (48.99)
Testing period from October to March (%) 705 (51.01)
Patients with 25(OH)D testing and follow-up until
birth
1153
Median maternal age at testing (years) 30 (IQR 22–38)
Median gestational age at testing (weeks) 12 (IQR 8–16)
Median BMI (kg/m2) 23 (IQR 16–30)
Smoking mothers (%) 70 (6.17)
Ethnic origin (%) European: 730 (63.31)
- Occidental - 443 (38.42)
- Southern - 76 (6.59)
- Eastern - 189 (16.39)
- Turkish - 22 (1.91)
Northern Africa 38 (3.30)
Middle East 72 (6.24)
South West Asia 54 (4.68)
Sub-Saharan Africa 197 (17.09)
Sri Lanka/India 62 (5.38)
Figure 1: Distribution of the population studied according to their ethnic origin.
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Risk factors for vitamin D deficiency during pregnan-
cy
Known risk factors for vitamin D deficiency were con-
firmed by our findings and are presented in table 3.
Patients who had blood samples taken during the period
from October to March were more likely to have a vitamin
D deficiency than those who were tested between April
and September (p <0.0001). Patients with higher BMI val-
ues were significantly more likely to suffer from vitamin
D deficiency (p <0.0001). Smoking was not found to be a
risk factor for vitamin D deficiency (p = 0.0924).
The statistical analysis demonstrated that subjects of Euro-
pean descent (including western + eastern + southern Eu-
rope and Turkey) and those from North Africa, the Middle
East and Asia, i.e., people with lighter skin, are significant-
ly less likely to show a vitamin D deficiency compared to
Africans or Sri Lankans/Indians (p <0.0001), i.e., people
Table 2: Distribution of vitamin D status among the 1382 patients with
vitamin D testing (total = 1382).
Sufficiency (%) 370 (26.77)
Mild deficiency (%) 538 (38.93)
Severe deficiency (%) 474 (34.30)
Mean serum level of 25(OH)D
(nmol/l)
36.72 (SD 19.6)
with darker skin living in Switzerland. The results for the
various ethnic groups are summarised in figures 2 and 3.
Associations between vitamin D status and pregnancy
outcomes
A statistically significant association with vitamin D defi-
ciency was found only for the development of gestational
diabetes (p = 0.0116; OR = 0.5932, 95%CI
0.3872–0.8826). Postpartum haemorrhage and placental
retention, which can be regrouped under “abnormalities of
third stage of labour”, were found to be less likely in pa-
tients with a lower vitamin D status (p = 0.0188 and p =
0.0277).
No significant association could be observed between the
vitamin D status and the occurrence of:
– bacterial vaginosis (p = 0.4420)
– pregnancy hypertension and/or preeclampsia (p =
0.1606)
– small-for-gestational-age newborn or intrauterine
growth retardation (p = 0.3695)
– prematurity (p = 0.3154)
– early miscarriage (p = 0.0892)
– caesarean delivery (p = 0.1992)
Table 3: Linear model for vitamin D status and risk factors*.
Variable Estimate Std error t value p-value
(Intercept) 3.8366 0.125895 30.4750 <0.0001
Ethnicity 0.6418 0.0372 17.2320 <0.0001
BMI −0.0220 0.0035 −6.2870 <0.0001
Smoking −0.0045 0.0615 −0.0730 0.9419
Season at testing −0.1950 0.0349 −5.5880 <0.0001
Gestational age at testing 0.0047 0.0030 1.5850 0.1133
* The modelled outcome was the numerical vitamin D status
Figure 2: Vitamin D status among the various ethnic origins.
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Interestingly, gestational age at birth was closely negative-
ly correlated with vitamin D level (correlation coefficient
−0.0978, 95%CI −0.1498 to −0.0453; p = 0.0003). This
means that low vitamin D levels were not associated with
preterm births, but on the contrary, the lower the vitamin D
level, the higher the gestational age at birth. No significant
correlations were found concerning newborn weight (p =
0.2006) or length (p = 0.5808).
The results concerning the associations between low vit-
amin D levels and pregnancy outcomes/complications are
presented in tables 4 and 5.
Discussion
Summary of results
Our study is the first large cross-sectional cohort study
of 25(OH)D level measurements in pregnant women in
Switzerland, showing that three quarters of them are vita-
min D deficient and over one third are severely vitamin D
deficient. This corresponds to our primary hypothesis that
pregnant women have a much higher prevalence of severe
vitamin D deficiency compared to the rate for the general
population in Switzerland stated in the Swiss Federal Com-
mission for Nutrition report [16]. This finding has conse-
quences for vitamin D supplementation recommendations
Figure 3: Mean value of 25(OH)D according to the various ethnic origins.
Table 4: Associations between vitamin D status and pregnancy outcomes.




SD OR 95% confidence inter-
val
p-value
Gestational diabetes 167 (14.5) 81.44 36.31 19.59 0.5932 0.3872–0.8826 0.0116
Bacterial vaginosis 36 (3.1) 77.78 40.62 19.41 0.6912 0.2730–1.5181 0.4420
Preeclampsia 24 (2.1) 87.50 33.46 19.37 0.4042 0.0914–1.1900 0.1606
SGA/IUGR 109 (9.5) 77.06 38.05 19.45 0.7961 0.4911–1.2473 0.3695
Prematurity 85 (7.4) 68.24 41.63 19.70 1.2769 0.7855–2.0322 0.3154
Miscarriage 46 (4) 84.78 36.56 19.54 0.5050 0.2030–1.0768 0.0892
Delivery by caesarean section 388 (33.7) 75.52 39.12 19.65 1.1968 0.9154–1.5744 0.1992
Prolonged pregnancy 129 (153) 74.42 (74.51) 41.99 (27.29) 19.64 0.9292 0.6056–1.3930 0.7558
Placental retention 46 (4) 58.70 46.73 19.39 1.9841 1.0709–3.6044 0.0277
Postpartum haemorrhage 90 (7.8) 62.22 46.34 19.60 1.7349 1.1023–2.6935 0.0188
IUGR = intrauterine growth restriction; OR = odds ratio; SD = standard deviation; SGA = small for gestational age
Table 5: Associations for numerical outcomes.
Outcome Mean value Standard devia-
tion
Correlation coefficient Confidence interval p-value
Weight of neonate at birth 3337.3g 1148.16 0.0434 −0.0231 to 0.1095 0.2006
Length of neonate at birth 49.3cm 2.83 −0.0189 −0.0858 to 0.0482 0.5808
Gestational age at birth 39th 2/7 2.35 −0.0978 −0.1498 to −0.0453 0.0003
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in Switzerland. Currently, supplementation of 600 IU is
recommended for all pregnant and breastfeeding women.
For women with a severe vitamin D deficiency, supple-
mentation of 1500–2000 IU is recommended, as stated in
the Swiss Federal Commission guidelines. However, gen-
eral serum measurements are not currently recommended.
The effect of the supplementation of 600 IU vitamin D on
25(OH)D levels can be estimated using the dose–response
calculations proposed by Heaney. The administration of
400 IU is expected to increase 25(OH)D concentrations by
about 10.0 nmol/l [33]. This means that even if 800 IU vi-
tamin D were to be supplemented to all pregnant women,
over a third would not reach the recommended minimum
threshold level of 50 nmol/l. There are recent publications
of RCTs highlighting the fact that a 600 IU daily supple-
ment is insufficient to prevent vitamin D deficiency, and
that higher dosing of vitamin D is required to establish suf-
ficiency [4, 21, 23].
Comparison with published research
The current literature contains conflicting evidence regard-
ing the association between vitamin deficiency and adverse
pregnancy outcomes. A recent Cochrane review of 30 ran-
domised and quasi-randomised trials concluded that sup-
plementing pregnant women with vitamin D alone proba-
bly reduces the risk of preeclampsia, gestational diabetes
and low birthweight, and may reduce the risk of severe
postpartum haemorrhage [34]. However, additional rigor-
ous, high-quality and larger randomised trials are required
to evaluate the effects of vitamin D supplementation in
pregnancy, particularly in relation to the risk of maternal
adverse events. This is in accordance with the conclusions
of many other studies and meta-analyses, with a wide het-
erogeneity of populations studied and applied methodolo-
gies for both vitamin D substitution and assessment, on the
relationship between maternal vitamin D status and preg-
nancy outcomes [35–37].
Measurement of vitamin D
In line with general clinical practice, we measured only to-
tal 25(OH)D. However, there are recent data indicating that
free 25(OH)D might be superior to routine total 25(OH)D
as a characteristic of vitamin D status in pregnancy [38].
Risk factors for vitamin D deficiency
Our findings regarding the prevalence of vitamin D defi-
ciency are in line with several published studies from all
over the world. One of them, conducted in northern Italy,
observed a prevalence of vitamin D deficiency of 70.6%
[39]. In a 2018 study from Saudi Arabia, the prevalence
was as high as 82.5% [40]. A Chinese study obtained al-
most the same result, with a prevalence of 82.6% [6]. On
the contrary, a recently published Australian study report-
ed a much lower percentage of pregnant women with a vi-
tamin D deficiency, but that difference can be easily ex-
plained by differences in sun exposure [41]. We found two
recently published Swiss studies that reported slightly low-
er prevalences of vitamin D deficiency. The first one in-
cluded 204 patients and focused on differences in the rates
of vitamin D deficiency detected in pregnant women de-
pending on their skin color. It found that overall, 63% of
these women were vitamin D deficient [42]. The second
study included 305 patients and obtained a prevalence of
vitamin D deficiency of 53.4% [43].
Our study confirms most of the risk factors for vitamin D
deficiency reported in the literature (winter season, BMI,
ethnic groups with darker skin, smoking status). Indeed,
our results show the presence of a significant seasonal vari-
ability of vitamin D status. We also found an inverse re-
lationship between vitamin D status and BMI, which is
explained by a smaller skin surface area for vitamin D syn-
thesis in comparison to the total body volume [44]. Our
results do not confirm smoking as a risk factor for vita-
min D [45]. Like several others [39, 42, 46–48], our study
confirms that populations from Southeast Asia and Africa
have a significantly higher risk of vitamin D deficiency
than the occidental population. This difference between the
various ethnic groups has been explained in the literature:
it is due to the degree of skin pigmentation, which influ-
ences the ability of the body to absorb sunlight for the syn-
thesis of vitamin D [1]. This is of increasing interest in
view of current global migration patterns.
Negative pregnancy outcomes
Gestational diabetes mellitus
Like numerous others, our study confirms the association
between low vitamin D levels and the occurrence of gesta-
tional diabetes mellitus (GDM) [40, 41, 46, 49]. An Aus-
tralian study from 2014 [46] reported a seven-fold increase
in the likelihood of developing GDM if the women were
vitamin D deficient during the early stages of pregnancy.
Another Australian study, published in 2018, observed a
53% decreased risk for gestational diabetes mellitus in
women with high (> 81 nmol/l) "standardised" vitamin D
status when compared to moderate to high (63−81 nmol/l)
[41]. In a multiethnic cohort of 745 pregnant women from
Norway, a higher proportion of women from ethnic mi-
norities had GDM (p <0.01) and low 25(OH)D levels (p
<0.01), compared to European women. However, after ad-
justments for confounding factors, in particular ethnicity,
vitamin D deficiency was not associated with GDM [50].
A meta-analysis from 2014, based on 20 observational
studies and regrouping up to 9200 patients, also indicated
a consistent association between vitamin D deficiency and
an increased risk of GDM [51]. A meta-analysis of 29
observational studies conducted in 2018, which included
28,982 participants of whom 4634 were diagnosed with
gestational diabetes, showed that maternal vitamin D in-
sufficiency was associated with a significant increase in
the risk of gestational diabetes of 39% (pooled OR 1.39,
95%CI 1.20−1.60), with moderate heterogeneity (I2
50.2%; p = 0.001) [52].
Another meta-analysis of 26 studies found that vitamin D
deficiency among mothers in general may be related to
an increased risk of gestational diabetes (OR 1.18, 95%CI
1.01−1.35; p <0.001). Subgroup analysis showed that the
results concerning this association may vary with study de-
sign but do not change with country of origin [53].
Gestational diabetes is strongly associated with an adverse
pregnancy outcome, as well as with long-term adverse ef-
fects on the offspring, which likely occur due to epigenet-
ic modifications of the fetal genome (fetal programming),
which is exposed to altered conditions in diabetic moth-
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ers. The impact of gestational diabetes in pregnancy and on
the offspring’s future shows a need to find efficient preven-
tion and intervention strategies. A question that should be
raised is whether vitamin D supplementation is helpful in
preventing the development of gestational diabetes, a con-
dition that develops in about 2–5% of all pregnant women
and has become considerably more common during the last
decade [54].
To our knowledge, three recently published double-blind
RCTs presented positive data regarding the effect of vita-
min D supplementation on GDM. Vitamin D supplemen-
tation during the first and second trimesters of pregnancy
was effective in reducing GDM and controlling the glucose
tolerance test [55]. A high dose of vitamin D supplementa-
tion (50,000 IU every 2 weeks) significantly improved in-
sulin resistance in pregnant women with GDM [56], and
supplementation among pregnant women with GDM re-
sulted in a decrease in the occurrence of maternal polyhy-
dramnios and infant hyperbilirubinemia compared with a
placebo [57].
Postpartum haemorrhage and placental retention
Surprisingly, our results show a significant inverse rela-
tionship between vitamin D status and the occurrence of
both postpartum haemorrhage and placental retention. We
do not have an explanation for this finding and very few
existing publications address this subject. A case-control
study found that women with uterine atony had a signifi-
cantly lower mean of vitamin D concentration than those
without uterine atony, which could be explained by the fact
that low vitamin D can result in muscle weakness. Another
study [46] did not find any such association.
Preeclampsia
Similar to our study, there have been observational studies
[46, 47] which showed negative results for any association
between vitamin D levels and preeclampsia. A meta-analy-
sis of 12 studies from 2014 [58] suggested that low ma-
ternal serum 25(OH)D concentrations increase the risk of
preeclampsia and that vitamin D supplementation lowers
this risk. However, the quality of evidence was insufficient
to determine a causal association. Another study [59],
based on data from up to 700 patients who developed
preeclampsia, concluded that vitamin D deficiency may be
a risk factor for severe preeclampsia, but that it is not asso-
ciated with preeclampsia overall or its mild subtypes. A re-
cently updated meta-analysis of 23 studies found that vita-
min D deficiency (25(OH)D <20 ng/ml = <50 nmol/l) was
significantly associated with a risk of preeclampsia (fixed
p <0.0001; random p = 0.0029; fixed OR = 1.33; random
OR = 1.54) and that this association can be specific up to
90% at a 10.60 ng/ml cut-off [60]. The findings on the rela-
tionship between vitamin D deficiency and preeclampsia in
the literature are therefore inconclusive, possibly because,
according to Hollis and Wagner, supplementation should
occur prior to placentation [21].
Low birth weight/SGA
Yet again, in agreement with our study, there are published
results showing a lack of any significant association be-
tween vitamin D and SGA and/or low birth weight. How-
ever, many observational studies [3, 61] have shown that
women with lower vitamin D levels are more likely to give
birth to SGA fetuses, and pregnant women who deliver
SGA fetuses have lower vitamin D levels. This has been
explained by the action of vitamin D on bone formation
and the known fact that birth weight is directly correlated
with skeletal growth.
Our results did not demonstrate any association between
vitamin D status and the occurrence of bacterial vaginosis,
pregnancy losses or prematurity.
Several observational studies [3, 51] have found that
women with a lower vitamin D status have a higher risk
of bacterial vaginosis. The underlying mechanism is pos-
sibly related to the role that calcitriol plays in the immune
system. By reducing susceptibility to infections, vitamin D
could also be a protective factor against the premature rup-
ture of the membranes and prevent prematurity.
Few studies concerning the connection between vitamin D
and prematurity are available. We found only one study
with significant results, a retrospective case–control study
[62] which concluded that vitamin D levels were signifi-
cantly lower in women who delivered at preterm compared
to in those who delivered at full term.
As an immune modulator, vitamin D also plays a role
in maternal immunosuppression, without which the fetus
could not survive. Therefore, vitamin D deficiency has
been implicated as a risk factor for recurrent pregnancy
losses. There is limited data available concerning this last
outcome. However, a recent study from Denmark reported
that concentrations of 25(OH)D <50 nmol/l were associ-
ated with a greater than two-fold increase in the adjusted
hazard ratio for first-semester miscarriage [63]. A recent
review of the literature on recurrent pregnancy loss includ-
ed 11 studies which reported a high prevalence of vitamin
D insufficiency/deficiency in women with recurrent preg-
nancy loss and suggested that this could be associated with
immunological dysregulation and consequently with recur-
rent pregnancy loss. However, there is currently no evi-
dence concerning the benefits of supplementation on this
outcome [64].
Mode of delivery
Few studies have assessed the mode of delivery. However,
most of those that have are similar to ours in the sense
that they did not demonstrate any significant association
between vitamin D and delivery by caesarean section [3,
46, 65]. In a cross-sectional study by Merewood et al. in
2009 [66], delivery by caesarean section was almost four
times more common in women with vitamin D levels <
37.5 nmol/l compared to those with levels over 80 nmol/l.
Similar to the ideas around uterine atony, the theory is that
low vitamin D can result in muscle weakness and negative-
ly affect the stages of labour.
Strengths of the study
This study is one of the first large studies presenting data
on the vitamin D status of pregnant women in the first
trimester in Switzerland. The data highlight the magnitude
of the problem and raise awareness of this global health is-
sue. Our data also show that vitamin D deficiency is not a
problem restricted to developing countries, but also affects
pregnant women in developed countries.
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These data also contribute to establishing a possible link
between vitamin D deficiency and gestational diabetes
mellitus.
This study has two further major strengths. The first is
the large number of included subjects. The second is that
the study population was not a selective cohort of typical
Swiss women, but a longitudinal sample of the overall pop-
ulation living in a modern Swiss city, which is much more
representative of the daily practice.
Limitations and weaknesses of the study
Limitations of this analysis result firstly from the retro-
spective nature of the study and the difficulty in recalling
past events. This may contribute to possible biases in the
study.
As we only included the most frequently studied adverse
maternal and fetal outcomes after a narrative review of the
literature, less frequent adverse events like hypercalcemia
of newborns were not included.
There are several parameters, like dietary and lifestyle
habits, sunshine exposure and clothing preferences, which
would have been of interest. However, we were unable to
obtain the data to allow us to include them in the analysis.
It would have also been quite interesting to incorporate the
follow-up results of the vitamin D levels from the second
and third trimesters. However, no results were available for
this population as we assumed that vitamin D levels would,
by then, have returned to the normal range. Nevertheless,
we now recognise that it would have been of value to check
the vitamin D levels. Therefore, we have subsequently in-
troduced a follow-up check of vitamin D levels in the sec-
ond trimester.
Due to the retrospective nature of the study, no structured
data on the vitamin D supplementation could be provided.
The pregnant subjects were reviewed every 5–6 weeks and
the history of adherence was taken, with compliance good
overall.
Low levels of vitamin D appear to be associated with both
positive and negative outcomes. Therefore, the resulting
available evidence needs to be interpreted with caution.
However, it remains unclear whether this association is
causal, owing to the observational design of the study.
We are aware that our findings must be interpreted with
caution and that further research is needed to provide more
evidence on this topic and to promote a change in the
guidelines.
Despite the many important health benefits of vitamin D,
there is controversy regarding the definition of vitamin D
deficiency and what the vitamin D requirement should be.
In addition, critical windows of exposure to adequate vita-
min D levels during fetal maturation remain to be defined
[67].
Conclusion
Our study shows a high prevalence of severe vitamin D de-
ficiency in pregnant women. Furthermore, the data suggest
that vitamin D deficiency is linked to gestational diabetes.
In our opinion, the current recommendations of vitamin
D supplementation of 600 IU in pregnant women are in-
sufficient to establish an adequate vitamin D level. Novel
strategies such as general 25(OH)D measurement in preg-
nancy and adjusted supplementation of vitamin D should
be evaluated in further studies, potentially leading to im-
proved maternal health and benefits to children’s long-term
health in Switzerland and worldwide. Pre-conception sup-
plementation of vitamin D, as is recommended for folic
acid, may even be considered as part of a novel approach,
so that women begin their pregnancy with already suffi-
cient levels of vitamin D, especially as there are no neg-
ative effects to be expected from starting supplementation
earlier.
Further well-designed studies are required to assess the
efficacy of targeted, 25(OH)D level-adjusted vitamin D
supplementation during pregnancy on vitamin D levels in
newborns and, finally, on clinical outcomes. This is of ut-
most importance, as ensuring a sufficient supply of vitamin
D in both the mother and the child has great potential for
the prevention of birth complications and significantly af-
fects the health of the child throughout his/her life.
Acknowledgments
The authors acknowledge the hospital, the gynaecologist-obstetricians,
the midwives and the patients who permitted the realisation of this
study. We would also like to acknowledge G. Fischer for his statistical
analysis.
Financial disclosure
The study was supported by a grant of the Research Fund, Department
of Obstetrics and Gynaecology, University Hospital Bern, Switzerland.
Potential competing interests
The authors have no conflicts of interest to declare.
References
1 Wacker M, Holick MF. Vitamin D - effects on skeletal and extraskeletal
health and the need for supplementation. Nutrients. 2013;5(1):111–48.
doi: http://dx.doi.org/10.3390/nu5010111. PubMed.
2 Kaushal M, Magon N. Vitamin D in pregnancy: A metabolic outlook.
Indian J Endocrinol Metab. 2013;17(1):76–82. doi: http://dx.doi.org/
10.4103/2230-8210.107862. PubMed.
3 Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O’Beirne M,
Rabi DM. Association between maternal serum 25-hydroxyvitamin D
level and pregnancy and neonatal outcomes: systematic review and
meta-analysis of observational studies. BMJ. 2013;346(mar26 4):f1169.
doi: http://dx.doi.org/10.1136/bmj.f1169. PubMed.
4 Dawodu A, Saadi HF, Bekdache G, Javed Y, Altaye M, Hollis BW.
Randomized controlled trial (RCT) of vitamin D supplementation in
pregnancy in a population with endemic vitamin D deficiency. J Clin
Endocrinol Metab. 2013;98(6):2337–46. doi: http://dx.doi.org/10.1210/
jc.2013-1154. PubMed.
5 Rostami M, Tehrani FR, Simbar M, Bidhendi Yarandi R, Minooee S,
Hollis BW, et al. Effectiveness of Prenatal Vitamin D Deficiency
Screening and Treatment Program: A Stratified Randomized Field Trial.
J Clin Endocrinol Metab. 2018;103(8):2936–48. doi: http://dx.doi.org/
10.1210/jc.2018-00109. PubMed.
6 Fu CW, Liu JT, Tu WJ, Yang JQ, Cao Y. Association between serum
25-hydroxyvitamin D levels measured 24 hours after delivery and post-
partum depression. BJOG. 2015;122(12):1688–94. doi: http://dx.doi.org/
10.1111/1471-0528.13111. PubMed.
7 McGrath J. Does ‘imprinting’ with low prenatal vitamin D contribute to
the risk of various adult disorders? Med Hypotheses.
2001;56(3):367–71. doi: http://dx.doi.org/10.1054/mehy.2000.1226.
PubMed.
8 Ponsonby AL, Lucas RM, Lewis S, Halliday J. Vitamin D status during
pregnancy and aspects of offspring health. Nutrients.
2010;2(3):389–407. doi: http://dx.doi.org/10.3390/nu2030389.
PubMed.
9 Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E. Vita-
min D supplementation during pregnancy: state of the evidence from a
systematic review of randomised trials. BMJ. 2017;359:j5237. doi:
http://dx.doi.org/10.1136/bmj.j5237. PubMed.
10 Schmidt RJ, Niu Q, Eyles DW, Hansen RL, Iosif AM. Neonatal vitamin
D status in relation to autism spectrum disorder and developmental de-
Original article Swiss Med Wkly. 2020;150:w20238
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 9 of 11
lay in the CHARGE case-control study. Autism Res.
2019;12(6):976–88. doi: http://dx.doi.org/10.1002/aur.2118. PubMed.
11 Al-Garawi A, Carey VJ, Chhabra D, Mirzakhani H, Morrow J, Lasky-
Su J, et al. The Role of Vitamin D in the Transcriptional Program of Hu-
man Pregnancy. PLoS One. 2016;11(10):e0163832. doi:
http://dx.doi.org/10.1371/journal.pone.0163832. PubMed.
12 Olsen SF, Secher NJ. A possible preventive effect of low-dose fish oil
on early delivery and pre-eclampsia: indications from a 50-year-old con-
trolled trial. Br J Nutr. 1990;64(3):599–609. doi: http://dx.doi.org/
10.1079/BJN19900063. PubMed.
13 Goldring ST, Griffiths CJ, Martineau AR, Robinson S, Yu C, Poulton S,
et al. Prenatal vitamin d supplementation and child respiratory health: a
randomised controlled trial. PLoS One. 2013;8(6):e66627. doi:
http://dx.doi.org/10.1371/journal.pone.0066627. PubMed.
14 Mirzakhani H, Litonjua AA, McElrath TF, O’Connor G, Lee-Parritz A,
Iverson R, et al. Early pregnancy vitamin D status and risk of
preeclampsia. J Clin Invest. 2016;126(12):4702–15. doi:
http://dx.doi.org/10.1172/JCI89031. PubMed.
15 Bahrami A, Sadeghnia HR, Tabatabaeizadeh SA, Bahrami-Taghanaki H,
Behboodi N, Esmaeili H, et al. Genetic and epigenetic factors influenc-
ing vitamin D status. J Cell Physiol. 2018;233(5):4033–43. doi:
http://dx.doi.org/10.1002/jcp.26216. PubMed.
16 Nutrition ESFCf. Vitamin D deficiency: Evidence, safety, and recom-
mendations for the Swiss Population. 2012, Swiss Federal Office for
Public Health.
17 World Health Organization. Guidelines: Vitamin D supplementation in
pregnant women. Geneva: WHO; 2012.
18 Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK,
et al. The 2011 report on dietary reference intakes for calcium and vita-
min D from the Institute of Medicine: what clinicians need to know. J
Clin Endocrinol Metab. 2011;96(1):53–8. doi: http://dx.doi.org/10.1210/
jc.2010-2704. PubMed.
19 Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-
Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvi-
tamin D for multiple health outcomes. Am J Clin Nutr.
2006;84(1):18–28. doi: http://dx.doi.org/10.1093/ajcn/84.1.18. PubMed.
20 EFSA Panel on Dietetic Products. Dietary reference values for vitamin
D. EFSA J. 2016;14(10):e04547. doi: http://dx.doi.org/10.2903/j.ef-
sa.2016.4547.
21 Hollis BW, Wagner CL. Vitamin D supplementation during pregnancy:
Improvements in birth outcomes and complications through direct ge-
nomic alteration. Mol Cell Endocrinol. 2017;453:113–30. doi:
http://dx.doi.org/10.1016/j.mce.2017.01.039. PubMed.
22 Bouillon R. Comparative analysis of nutritional guidelines for vitamin
D. Nat Rev Endocrinol. 2017;13(8):466–79. doi: http://dx.doi.org/
10.1038/nrendo.2017.31. PubMed.
23 Enkhmaa D, Tanz L, Ganmaa D, Enkhtur S, Oyun-Erdene B, Stuart J, et
al. Randomized trial of three doses of vitamin D to reduce deficiency in
pregnant Mongolian women. EBioMedicine. 2019;39:510–9. doi:
http://dx.doi.org/10.1016/j.ebiom.2018.11.060. PubMed.
24 Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D
supplementation during pregnancy: double-blind, randomized clinical
trial of safety and effectiveness. J Bone Miner Res.
2011;26(10):2341–57. doi: http://dx.doi.org/10.1002/jbmr.463.
PubMed.
25 Wolsk HM, Chawes BL, Litonjua AA, Hollis BW, Waage J, Stokholm J,
et al. Prenatal vitamin D supplementation reduces risk of asthma/recur-
rent wheeze in early childhood: A combined analysis of two randomized
controlled trials. PLoS One. 2017;12(10):e0186657. doi:
http://dx.doi.org/10.1371/journal.pone.0186657. PubMed.
26 Thorp JM, Camargo CA, McGee PL, Harper M, Klebanoff MA, Sorokin
Y, et al.; Eunice Kennedy Shriver National Institute of Child Health and
Human Development Maternal-Fetal Medicine Units Network. Vitamin
D status and recurrent preterm birth: a nested case-control study in high-
risk women. BJOG. 2012;119(13):1617–23. doi: http://dx.doi.org/
10.1111/j.1471-0528.2012.03495.x. PubMed.
27 Abedi P, Mohaghegh Z, Afshary P, Latifi M. The relationship of serum
vitamin D with pre-eclampsia in the Iranian women. Matern Child Nutr.
2014;10(2):206–12. doi: http://dx.doi.org/10.1111/mcn.12058. PubMed.
28 Bennett SE, McPeake J, McCance DR, Manderson JG, Johnston P, Mc-
Galliard R, et al. Maternal vitamin D status in Type 1 diabetic pregnan-
cy: Impact on neonatal vitamin D status and association with maternal
glycaemic control. Pregnancy Hypertens. 2014;4(3):235–6. doi:
http://dx.doi.org/10.1016/j.preghy.2014.03.020. PubMed.
29 Mutlu N, Esra H, Begum A, Fatma D, Arzu Y, Yalcin H, et al. Relation
of maternal vitamin D status with gestational diabetes mellitus and peri-
natal outcome. Afr Health Sci. 2015;15(2):523–31. doi:
http://dx.doi.org/10.4314/ahs.v15i2.27. PubMed.
30 Kiely ME, Zhang JY, Kinsella M, Khashan AS, Kenny LC. Vitamin D
status is associated with uteroplacental dysfunction indicated by pre-
eclampsia and small-for-gestational-age birth in a large prospective
pregnancy cohort in Ireland with low vitamin D status. Am J Clin Nutr.
2016;104(2):354–61. doi: http://dx.doi.org/10.3945/ajcn.116.130419.
PubMed.
31 Wagner CL, McNeil RB, Johnson DD, Hulsey TC, Ebeling M, Robinson
C, et al. Health characteristics and outcomes of two randomized vitamin
D supplementation trials during pregnancy: a combined analysis. J
Steroid Biochem Mol Biol. 2013;136:313–20. doi: http://dx.doi.org/
10.1016/j.jsbmb.2013.01.002. PubMed.
32 Jefferson KK, Parikh HI, Garcia EM, Edwards DJ, Serrano MG, Hewi-
son M, et al. Relationship between vitamin D status and the vaginal mi-
crobiome during pregnancy. J Perinatol. 2019;39(6):824–36. doi:
http://dx.doi.org/10.1038/s41372-019-0343-8. PubMed.
33 Heaney RP. The Vitamin D requirement in health and disease. J Steroid
Biochem Mol Biol. 2005;97(1-2):13–9. doi: http://dx.doi.org/10.1016/
j.jsbmb.2005.06.020. PubMed.
34 Palacios C, Kostiuk LK, Peña-Rosas JP. Vitamin D supplementation for
women during pregnancy. Cochrane Database Syst Rev.
2019;7:CD008873. doi: http://dx.doi.org/10.1002/
14651858.CD008873.pub4. PubMed.
35 von Websky K, Hasan AA, Reichetzeder C, Tsuprykov O, Hocher B.
Impact of vitamin D on pregnancy-related disorders and on offspring
outcome. J Steroid Biochem Mol Biol. 2018;180:51–64. doi:
http://dx.doi.org/10.1016/j.jsbmb.2017.11.008. PubMed.
36 Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E. Vita-
min D supplementation during pregnancy: state of the evidence from a
systematic review of randomised trials. BMJ. 2017;359:j5237. doi:
http://dx.doi.org/10.1136/bmj.j5237. PubMed.
37 Reichetzeder C, Chen H, Föller M, Slowinski T, Li J, Chen YP, et al.
Maternal vitamin D deficiency and fetal programming--lessons learned
from humans and mice. Kidney Blood Press Res. 2014;39(4):315–29.
doi: http://dx.doi.org/10.1159/000355809. PubMed.
38 Tsuprykov O, Chen X, Hocher CF, Skoblo R, Lianghong Yin , Hocher
B. Why should we measure free 25(OH) vitamin D? J Steroid Biochem
Mol Biol. 2018;180:87–104. doi: http://dx.doi.org/10.1016/j.js-
bmb.2017.11.014. PubMed.
39 Cadario F, Savastio S, Magnani C, Cena T, Pagliardini V, Bellomo G, et
al. High Prevalence of Vitamin D Deficiency in Native versus Migrant
Mothers and Newborns in the North of Italy: A Call to Act with a
Stronger Prevention Program. PLoS One. 2015;10(6):e0129586. doi:
http://dx.doi.org/10.1371/journal.pone.0129586. PubMed.
40 Al-Ajlan A, Al-Musharaf S, Fouda MA, Krishnaswamy S, Wani K,
Aljohani NJ, et al. Lower vitamin D levels in Saudi pregnant women are
associated with higher risk of developing GDM. BMC Pregnancy Child-
birth. 2018;18(1):86. doi: http://dx.doi.org/10.1186/s12884-018-1723-3.
PubMed.
41 Wilson RL, Leviton AJ, Leemaqz SY, Anderson PH, Grieger JA,
Grzeskowiak LE, et al. Vitamin D levels in an Australian and New
Zealand cohort and the association with pregnancy outcome. BMC Preg-
nancy Childbirth. 2018;18(1):251. doi: http://dx.doi.org/10.1186/
s12884-018-1887-x. PubMed.
42 Richard A, Rohrmann S, Quack Lötscher KC. Prevalence of Vitamin D
Deficiency and Its Associations with Skin Color in Pregnant Women in
the First Trimester in a Sample from Switzerland. Nutrients.
2017;9(3):260. doi: http://dx.doi.org/10.3390/nu9030260. PubMed.
43 Krieger JP, Cabaset S, Canonica C, Christoffel L, Richard A, Schröder
T, et al. Prevalence and determinants of vitamin D deficiency in the
third trimester of pregnancy: a multicentre study in Switzerland. Br J
Nutr. 2018;119(3):299–309. doi: http://dx.doi.org/10.1017/
S0007114517003634. PubMed.
44 Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J. The de-
pendency of vitamin D status on body mass index, gender, age and sea-
son. Anticancer Res. 2009;29(9):3713–20. PubMed.
45 Banihosseini SZ, Baheiraei A, Shirzad N, Heshmat R, Mohsenifar A.
The effect of cigarette smoke exposure on vitamin D level and biochem-
ical parameters of mothers and neonates. J Diabetes Metab Disord.
2013;12(1):19. doi: http://dx.doi.org/10.1186/2251-6581-12-19.
PubMed.
46 Davies-Tuck M, Yim C, Knight M, Hodges R, Doery JC, Wallace E. Vi-
tamin D testing in pregnancy: Does one size fit all? Aust N Z J Obstet
Gynaecol. 2015;55(2):149–55. doi: http://dx.doi.org/10.1111/ajo.12278.
PubMed.
47 Flood-Nichols SK, Tinnemore D, Huang RR, Napolitano PG, Ippolito
DL. Vitamin D deficiency in early pregnancy. PLoS One.
2015;10(4):e0123763. doi: http://dx.doi.org/10.1371/jour-
nal.pone.0123763. PubMed.
Original article Swiss Med Wkly. 2020;150:w20238
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 10 of 11
48 van der Meer IM, Karamali NS, Boeke AJ, Lips P, Middelkoop BJ, Ver-
hoeven I, et al. High prevalence of vitamin D deficiency in pregnant
non-Western women in The Hague, Netherlands. Am J Clin Nutr.
2006;84(2):350–3, quiz 468–9. doi: http://dx.doi.org/10.1093/ajcn/
84.2.350. PubMed.
49 Xu C, Ma HH, Wang Y. Maternal Early Pregnancy Plasma Concentra-
tion of 25-Hydroxyvitamin D and Risk of Gestational Diabetes Mellitus.
Calcif Tissue Int. 2018;102(3):280–6. doi: http://dx.doi.org/10.1007/
s00223-017-0346-4. PubMed.
50 Eggemoen AR, Waage CW, Sletner L, Gulseth HL, Birkeland KI,
Jenum AK. Vitamin D, Gestational Diabetes, and Measures of Glucose
Metabolism in a Population-Based Multiethnic Cohort. J Diabetes Res.
2018;2018:8939235. doi: http://dx.doi.org/10.1155/2018/8939235.
PubMed.
51 Zhang MX, Pan GT, Guo JF, Li BY, Qin LQ, Zhang ZL. Vitamin D De-
ficiency Increases the Risk of Gestational Diabetes Mellitus: A Meta-
Analysis of Observational Studies. Nutrients. 2015;7(10):8366–75. doi:
http://dx.doi.org/10.3390/nu7105398. PubMed.
52 Hu L, Zhang Y, Wang X, You L, Xu P, Cui X, et al. Maternal Vitamin D
Status and Risk of Gestational Diabetes: a Meta-Analysis. Cell Physiol
Biochem. 2018;45(1):291–300. doi: http://dx.doi.org/10.1159/
000486810. PubMed.
53 Amraei M, Mohamadpour S, Sayehmiri K, Mousavi SF, Shirzadpour E,
Moayeri A. Effects of Vitamin D Deficiency on Incidence Risk of Ges-
tational Diabetes Mellitus: A Systematic Review and Meta-analysis.
Front Endocrinol (Lausanne). 2018;9:7. doi: http://dx.doi.org/10.3389/
fendo.2018.00007. PubMed.
54 Monteiro LJ, Norman JE, Rice GE, Illanes SE. Fetal programming and
gestational diabetes mellitus. Placenta. 2016;48(Suppl 1):S54–60. doi:
http://dx.doi.org/10.1016/j.placenta.2015.11.015. PubMed.
55 Shahgheibi S, Farhadifar F, Pouya B. The effect of vitamin D supple-
mentation on gestational diabetes in high-risk women: Results from a
randomized placebo-controlled trial. J Res Med Sci. 2016;21(1):2. doi:
http://dx.doi.org/10.4103/1735-1995.175148. PubMed.
56 Zhang Q, Cheng Y, He M, Li T, Ma Z, Cheng H. Effect of various doses
of vitamin D supplementation on pregnant women with gestational dia-
betes mellitus: A randomized controlled trial. Exp Ther Med.
2016;12(3):1889–95. doi: http://dx.doi.org/10.3892/etm.2016.3515.
PubMed.
57 Asemi Z, Karamali M, Esmaillzadeh A. Favorable effects of vitamin D
supplementation on pregnancy outcomes in gestational diabetes: a dou-
ble blind randomized controlled clinical trial. Horm Metab Res.
2015;47(8):565–70. PubMed.
58 Hyppönen E, Cavadino A, Williams D, Fraser A, Vereczkey A, Fraser
WD, et al. Vitamin D and pre-eclampsia: original data, systematic re-
view and meta-analysis. Ann Nutr Metab. 2013;63(4):331–40. doi:
http://dx.doi.org/10.1159/000358338. PubMed.
59 Bakacak M, Serin S, Ercan O, Köstü B, Avci F, Kılınç M, et al. Compar-
ison of Vitamin D levels in cases with preeclampsia, eclampsia and
healthy pregnant women. Int J Clin Exp Med. 2015;8(9):16280–6.
PubMed.
60 Akbari S, Khodadadi B, Ahmadi SAY, Abbaszadeh S, Shahsavar F. As-
sociation of vitamin D level and vitamin D deficiency with risk of
preeclampsia: A systematic review and updated meta-analysis. Taiwan J
Obstet Gynecol. 2018;57(2):241–7. doi: http://dx.doi.org/10.1016/
j.tjog.2018.02.013. PubMed.
61 Olmos-Ortiz A, Avila E, Durand-Carbajal M, Díaz L. Regulation of cal-
citriol biosynthesis and activity: focus on gestational vitamin D deficien-
cy and adverse pregnancy outcomes. Nutrients. 2015;7(1):443–80. doi:
http://dx.doi.org/10.3390/nu7010443. PubMed.
62 Thota C, Menon R, Fortunato SJ, Brou L, Lee JE, Al-Hendy A. 1,25-Di-
hydroxyvitamin D deficiency is associated with preterm birth in African
American and Caucasian women. Reprod Sci. 2014;21(2):244–50. doi:
http://dx.doi.org/10.1177/1933719113493513. PubMed.
63 Andersen LB, Jørgensen JS, Jensen TK, Dalgård C, Barington T,
Nielsen J, et al. Vitamin D insufficiency is associated with increased risk
of first-trimester miscarriage in the Odense Child Cohort. Am J Clin Nu-
tr. 2015;102(3):633–8. doi: http://dx.doi.org/10.3945/ajcn.114.103655.
PubMed.
64 Gonçalves DR, Braga A, Braga J, Marinho A. Recurrent pregnancy loss
and vitamin D: A review of the literature. Am J Reprod Immunol.
2018;80(5):e13022. doi: http://dx.doi.org/10.1111/aji.13022. PubMed.
65 Gernand AD, Klebanoff MA, Simhan HN, Bodnar LM. Maternal vita-
min D status, prolonged labor, cesarean delivery and instrumental deliv-
ery in an era with a low cesarean rate. J Perinatol. 2015;35(1):23–8. doi:
http://dx.doi.org/10.1038/jp.2014.139. PubMed.
66 Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF. Associa-
tion between vitamin D deficiency and primary cesarean section. J Clin
Endocrinol Metab. 2009;94(3):940–5. doi: http://dx.doi.org/10.1210/
jc.2008-1217. PubMed.
67 Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspec-
tive. Mayo Clin Proc. 2013;88(7):720–55. doi: http://dx.doi.org/
10.1016/j.mayocp.2013.05.011. PubMed.
Original article Swiss Med Wkly. 2020;150:w20238
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 11 of 11
